OIC Receives FDA Clearance for IM Nail Line

July 21, 2015 (Reno,  NV) – The Orthopaedic Implant Company (OIC), the leading value innovator in orthopaedic implants, today announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) to market the OIC Intramedullary (IM) Nail System.  The OIC IM Nail System consists of hip , antegrade and retrograde femur, trochanteric […]

Read More

OIC Joins Membership of the International Geriatric Fracture Society

  July 8th, 2015 (Reno, NV) – OIC announced today its corporate membership for the International Geriatric Fracture Society (IGFS, www.geriatricfracture.org).   Headed by President Michael Suk, MD JD MPH FACS, the Society’s strategy is to promote and implement order sets and treatment protocols that have proven results in the treatment of geriatric fractures globally. “Given […]

Read More